Trending...
- Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
- Live Good Leads with Love: Creating Opportunity, Protecting the Vulnerable and Inspiring Hope
- RJ Grimshaw Launches "The AI EDGE" A Practical Guide Where Leadership Meets Innovation
FAYETTEVILLE, Ark. & SEATTLE - OhioPen -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network with the addition of CoMedical, a vascular access distribution company that services the Pacific Northwest. CoMedical, founded in 1980 and headquartered in Seattle Washington, is a medical device distributor specializing in the distribution and sale of vascular access products. CoMedical's sales team consisting of 6 members services Alaska, Idaho, Montana, Oregon and Washington on behalf of Lineus Medical.
"CoMedical is excited to be a partner with Lineus Medical in distributing SafeBreak Vascular in the Pacific Northwest. We are constantly reviewing the competitive landscape and searching for innovative products that we believe will bring tremendous value to our hospital clients and to their patients. SafeBreak Vascular fits that mold, and we believe it will improve peripheral IV access - the life line for many patients.", said Alison Donsky, Principal at CoMedical.
Vance Clement, CEO of Lineus Medical stated, "Launching a new class of medical device is hard work. CoMedical is a well experienced and nationally respected vascular access distribution company with a long history of success. Having CoMedical represent Lineus Medical and SafeBreak Vascular in the Pacific Northwest creates a win-win opportunity for both our companies. Lineus Medical is excited about the strong customer relationships that CoMedical brings to the table, and CoMedical understands the value of having a new and innovative product in their product portfolio."
More on Ohio Pen
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a January 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually.
More on Ohio Pen
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
MKG-0104
1D.I.P.P.E.R Study - Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
"CoMedical is excited to be a partner with Lineus Medical in distributing SafeBreak Vascular in the Pacific Northwest. We are constantly reviewing the competitive landscape and searching for innovative products that we believe will bring tremendous value to our hospital clients and to their patients. SafeBreak Vascular fits that mold, and we believe it will improve peripheral IV access - the life line for many patients.", said Alison Donsky, Principal at CoMedical.
Vance Clement, CEO of Lineus Medical stated, "Launching a new class of medical device is hard work. CoMedical is a well experienced and nationally respected vascular access distribution company with a long history of success. Having CoMedical represent Lineus Medical and SafeBreak Vascular in the Pacific Northwest creates a win-win opportunity for both our companies. Lineus Medical is excited about the strong customer relationships that CoMedical brings to the table, and CoMedical understands the value of having a new and innovative product in their product portfolio."
More on Ohio Pen
- Bùng Nổ Ra Mắt, AALIVE Tung Gói Thưởng 68% và Dàn Game Thuần Việt Hấp Dẫn
- ARCH Dental + Aesthetics Offers Free Consultations for New Patients
- Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida
- Multi-Signature Cold Storage: Keyanb Introduces Institutional-Grade Asset Protection for Chilean Crypto Traders
- NKSCX Introduces Zero-Knowledge Proof of Solvency for U.S. Traders Amid $6.5 Billion Fraud Crisis
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a January 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually.
More on Ohio Pen
- New Oasis International Foundation Announces Strategic Partnership Network Across 15 Countries to Advance Community-Led Economic Development
- Some Music for Donald's Bad Day
- New You Smile Dental Implant Center Expands Office
- $8 Billion High-Margin National Gentlemen's Club Market Targeted by Acquisition Strategy Incorporating the Successful Peppermint Hippo™ Brand: $TRWD
- Why Indian Game Development Companies Are Shaping the Future of Global Gaming
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
MKG-0104
1D.I.P.P.E.R Study - Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
Source: Lineus Medical
Filed Under: Technology
0 Comments
Latest on Ohio Pen
- UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- White Glove Restoration Sends "Help in Boxes" to Support Communities in Ghana
- Trayak Unveils AI-First EcoImpact Sustainability Platform
- NASA Agreements, New Ocean Exploration Applications Added to Partnerships with Defiant Space Corp and Emtel Energy USA for Solar Tech Leader: $ASTI
- OutbounderARS™ Cincinnati Hosts Private Open House for Breakthrough Neuro - Rehab Platform — October 30
- Chic and Secure: The Blue Luna Debuts Stylish Keychains with Purpose
- BEC Technologies Showcases Leadership in Private Broadband Ecosystem with Inclusion in UTC's Ecosystem Summary Report
- $500,000 in Stock Dividend for Shareholders in 2025 Sweetens The Pot on Success of Becoming Debt Free with No Convertible Notes or Warrants for $IQST
- Milwaukee Job Corps Center: Essential Workforce Training—Admissions Now Open
- Aissist.io Launches Hybrid AI Workforce to Solve AI Pilot Failure for Customer Support Automation
- Christy Sports Makes Snowsports More Accessible for Families to Get Outside Together
- MainConcept Completes Management Buyout to Become Independent Company
- LIB Industry Expands Full-Series Salt Spray Corrosion Test Chambers to Meet Global Testing Standards
- LKPFM Corp Annual message to Shareholders